Literature DB >> 33160838

Pediatric lung function testing during a pandemic: An international perspective.

N Beydon1, L Gochicoa2, M J Jones3, L C Lands4, E Lombardi5, M Rosenfeld6, P D Sly7, D J Weiner8, O Yilmaz9.   

Abstract

The COVID pandemic has passed its first peak for now in many countries while some are still on the rise, with some facing a second wave of cases. Precautions and infection control measures for both pediatric and adult pulmonary function testing (PFT) have been a topic of debate during the pandemic. Many centers had to close their PFT laboratories during the initial periods of the pandemic and are reopening as the numbers of new cases are decreasing. This review aims to summarize different practices of PFT laboratory management in different countries, including patient appointments, personal protective equipment, testing room requirements and telemedicine during and immediately following the COVID pandemic.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  COVID-19; Pandemic; Pediatric pulmonary function testing

Mesh:

Year:  2020        PMID: 33160838      PMCID: PMC7548117          DOI: 10.1016/j.prrv.2020.10.001

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


The reader will be able to: Summarize different practices of pediatric pulmonary lung function testing laboratory management in different countries. Identify the change in indications of pulmonary lung function testing in pediatric patients during and right after the pandemic.

Introduction

The World Health Organization reported nearly 13 million cases of COVID-19 worldwide as of July, 2020 [1]. Children constitute a small proportion of people diagnosed with COVID-19 and generally have a more benign disease and course compared to adults [2], [3], [4]. The main features in children have been fever, cough and the diagnosis of pneumonia [2]. Considering that there is a possibility of disease transmission to the patients and staff from asymptomatic carriers, precautions for pulmonary function testing (PFT) laboratories have been controversial [5]. Many professional societies have published recommendations for precautions during PFT [6], [7], [8], [9]. These include postponing testing in non-urgent cases, personal protective equipment (PPE) for the respiratory technicians and PFT lab room characteristics such as negative pressure and adequate ventilation, HEPA filters, extensive hygiene measures and social distancing [6], [7], [8], [9]. Moreover, PFT must be avoided in suspected or confirmed COVID-19 cases [7]. Pediatric PFT labs have been closed during the pandemic in most hospitals except for emergency cases but are reopening in countries with a decrease in the number of cases. This review summarizes the international practice in different centers around the world aiming to emphasize similarities and differences in regional barriers and opportunities.

Preparations before pediatric pulmonary function testing

Preparations before PFT concern two populations in pediatric care: the parents and the children. In most hospitals, families are screened with questionnaires about cough, shortness of breath, fever, loss of taste or smell, unusual fatigue or rhinitis/sinusitis and exposure to patients with COVID-19. If symptoms suggestive of COVID are reported, the test is re-scheduled until the result of COVID testing is available. The number of patients that can be seen has decreased in all centers owing to the increased time between tests required for adequate decontamination and air exchanges. The patients are usually scheduled with no overlap to avoid congregation in the waiting area. Moreover, only one person is allowed to accompany the child when he or she presents for the appointment. Patients and visitors to the hospital are questioned about symptoms and contact on arrival, and in many hospitals no-contact temperature is measured at the hospital entrance. Some centers prescreen patients by phone within 48 h prior to appointments. At some centers, a negative COVID test is required within 72 h before performing PFTs. Patients and visitors are expected to have a face mask/covering to enter the hospital. Moreover, they are asked to use hand sanitizer. Face masks are required for patients and families except for children younger than 6 years (note some places under 10, some under 12 years of age). In some hospitals patients that arrive for a scheduled PFT are taken directly into the room where testing will be performed. In hospitals where waiting rooms are large enough to organize seats in compliance with social distancing rules or where environmental conditions allow waiting out of the hospital, overlapping of appointments is not a major problem, but the waiting room and door handles still need to be disinfected several times a day. In areas where climate allows waiting outside the hospital, patients may wait in an outdoor area. In hospitals with negative pressure PFT labs with 8–11 air exchanges per hour, urgent PFTs that cannot be postponed despite COVID suspicion, are performed with the lab personnel wearing full COVID personal protective equipment (PPE).

The requirements for pediatric pulmonary function testing

The testing room: Every hospital has different environment conditions that influence the PFT practice. The number of air exchanges determines how quickly aerosol droplets are removed from the environment. With negative pressure rooms providing 8–11 air exchanges per hour or rooms equipped with portable or integrated HEPA filters, a delay is not required between patients. This may not be feasible in all hospitals; at some centers, PFTs are performed in rooms with windows that open outside. If these conditions do not exist, then there should be a 30-min waiting time between patients. Other measures include: continuous air purifying respiratory (CAPRs) use, adding a plexiglass (Perspex) divider between the patient and therapist (Table 1 ). All surfaces in the testing room such as the equipment, chairs, tables and plexiglass are wiped down with sanitizers after each patient. The testing equipment: Mouthpiece filters with bacterial and viral filtration efficiency of ≥99% are used for all measurements so the flow sensors do not need to be changed nor cleaned between patients.
Table 1

Potential measures that can be taken for protection of the lung function test personnel for tidal breathing and forced measurements.

MethodProposed protection measures for the personnel
Techniques involving larger expiration than tidal volume and/or forced (spirometry, DLCO, FeNO, MIP/MEP etc)

Wearing FFP2 (N95) masks, gowns, gloves and face shield or goggles

Continuous air purifying respiratory (CAPRs) use

Adding a plexiglass (Perspex) divider between the patient and therapist




Tidal breathing techniques (multiple breathing nitrogen washout, interrupter technique (Rint), oscillometry etc)

Wear surgical face masks, gloves

Potential measures that can be taken for protection of the lung function test personnel for tidal breathing and forced measurements. Wearing FFP2 (N95) masks, gowns, gloves and face shield or goggles Continuous air purifying respiratory (CAPRs) use Adding a plexiglass (Perspex) divider between the patient and therapist Wear surgical face masks, gloves Procedures and aerosol generation: There has been a lot of debate regarding which procedures are aerosol generating; and while tidal breathing tests such as oscillometry or Rint and plethysmography are considered as not being aerosol generating, maneuvers that induce cough, including spirometry and bronchial provocation tests, are more likely to generate aerosols. Methacholine challenge testing may not be undertaken in many centers since it typically induces cough and requires nebulization. Exercise testing is another challenging PFT during the pandemic period since it results in high minute ventilation and may induce cough. Moreover, there is concern that filters may cause resistance during the high minute ventilation with exercise. Testing order: Independent of the epidemic, tidal breathing tests are done before forced expiration maneuver to prevent changes in static volumes and bronchial caliber. Therefore, during the pandemic tidal breathing tests such as Functional residual capacity (FRC) dilution, resistance, Tlco rebreathing are performed first, followed by slow expiration and inspiration tests such as FeNO, nasal NO, slow vital capacity (SVC), static volumes, TlcoBH, P max and Sniff nasal inspiratory pressure (Snip). Finally, forced expiration and exercise tests are performed. The main idea is to have more aerosol generating tests, such as inducing sputum, performed after less aerosol generating tests, such as tidal breathing PFTs, in most centers, in order to leave the testing room right after the completion of the former. Testing personnel: Respiratory therapists or nurses performing all types of pulmonary function testing are screened daily for COVID symptoms by questionnaires and by temperature measurement in many centers. Moreover, home isolation if symptoms of fever, coryza and cough develop and PCR testing is mandatory in some institutions. Respiratory therapists or nurses performing forced expiration techniques such as spirometry, DLCO and FeNO are required to wear a mask; in some centers or situations, this mask must be a FFP2 (equivalent of N95) mask. Otherwise, in all situations wearing gowns, gloves and face shield or goggles for testing is required in most hospitals. Moreover, testing that is likely to cause cough such as bronchial challenge and testing that leads to high minute ventilation such as exercise testing require full protective measures. For tidal breathing techniques [helium dilution (FRChe), multiple breathing nitrogen washout (MBNW), interrupter technique (Rint), oscillometry, tidal breathing indices in infants, etc.) or closed plethysmography techniques, the professionals performing the PFT wear surgical face masks, gloves (because of risk of contact with respiratory secretions) with gloves changed between patients (Table 1).

Pediatric pulmonary function testing indications

The indications for PFT in children do not change with the pandemic as stated in previous guidelines [10]. However, the risk to other patients and staff must be carefully weighed against the benefits to the patient. In many hospital settings the indications for performing PFTs have been narrowed to include only the cases where diagnosis or acute management will change with the results of the PFT.

Considerations for specific patient groups

Patients with cystic fibrosis are amongst the most commonly tested in the pediatric pulmonology departments. These patients and their families are already quite familiar with infection control measures such as wearing a mask and practicing social distancing. The decision to perform PFTs in these patients is evaluated on individual basis. While spirometry may be very valuable in guiding treatment, most clinics are postponing plethysmography, cardiopulmonary exercise testing and six-minute walk test in these patients. Home spirometry is a potentially promising alternative to office/clinic spirometry that can avoid the need for office/clinic visits and allow for more frequent monitoring. There has been rapid uptake of home spirometry in some regions and innovations are accelerating. However, there are still a number of unknowns that must be acknowledged, including accuracy, repeatability, clinical significance of acute declines, need for coaching and long-term patient adherence [11], [12]. Home spirometry use for specific populations may be an alternative for selected populations such as the asthmatics in the long term but it will require training of the subjects to fulfill the standards. The COVID-19 pandemic has also impacted scientific research that requires PFT as part of the protocol. Many researchers postponed PFT measurements in the study population without clinical indications. This will be a major limitation for ongoing research in addition to the cancellation of in-person visits for these subjects. In conclusion, PFT laboratories are re-opening in areas of the world where there is decreased number of new COVID-19 cases; but generally, with reduced activity at the beginning. As experience and confidence with operating under restrictions is gained, activity increases. If there is a local increase of the case numbers, it is always possible to decrease the activity in an attempt to decrease contact. However, in the long term, it is probable that some changes implemented in the PFT labs during this pandemic will stay in daily practice even with no or low virus circulation (Table 2 ).
Table 2

Changes implemented in the pulmonary function testing laboratories that are expected to be permanent even after the pandemic.

Change Implemented
Before the test

Indications for PFT testing is narrowed

Patient scheduling with compliance expectations for the caregiver

Waiting room restrictions to allow social distancing

Questionnaire and no-contact temperature measurements on the day of the test




During the Test

Mouthpiece filters with viral and bacterial efficacy

Personal protective requirements for the respiratory technician or nurse performing the test




After the test

Wiping down all surfaces with sanitizers after each patients

Waiting period between patients depending on the air exchange rate in the room

Changes implemented in the pulmonary function testing laboratories that are expected to be permanent even after the pandemic. Indications for PFT testing is narrowed Patient scheduling with compliance expectations for the caregiver Waiting room restrictions to allow social distancing Questionnaire and no-contact temperature measurements on the day of the test Mouthpiece filters with viral and bacterial efficacy Personal protective requirements for the respiratory technician or nurse performing the test Wiping down all surfaces with sanitizers after each patients Waiting period between patients depending on the air exchange rate in the room

Directions for future research

The pandemic has necessitated reorganization of the pediatric pulmonary function testing (PFT) laboratories and practice. Future research on the extent of aerosol generation during various PFT techniques is needed for meticulous protection of the patients and health care personnel performing the procedure. Moreover, research to improve implementation of telemedicine in patient care will be important.
  8 in total

Review 1.  An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children.

Authors:  Nicole Beydon; Stephanie D Davis; Enrico Lombardi; Julian L Allen; Hubertus G M Arets; Paul Aurora; Hans Bisgaard; G Michael Davis; Francine M Ducharme; Howard Eigen; Monika Gappa; Claude Gaultier; Per M Gustafsson; Graham L Hall; Zoltán Hantos; Michael J R Healy; Marcus H Jones; Bent Klug; Karin C Lødrup Carlsen; Sheila A McKenzie; Francçois Marchal; Oscar H Mayer; Peter J F M Merkus; Mohy G Morris; Ellie Oostveen; J Jane Pillow; Paul C Seddon; Michael Silverman; Peter D Sly; Janet Stocks; Robert S Tepper; Daphna Vilozni; Nicola M Wilson
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

2.  Delivery of high-quality pediatric spirometry in rural communities: A novel use for telemedicine.

Authors:  Ariel Berlinski; Sheva K Chervinskiy; A Larry Simmons; Pamela Leisenring; Shawn A Harwell; Devaney J Lawrence; Stacie M Jones; John L Carroll; Tamara T Perry
Journal:  J Allergy Clin Immunol Pract       Date:  2018-02-08

3.  Italian pediatric respiratory society recommendations on pediatric pulmonary function testing during COVID-19 pandemic.

Authors:  Elisabetta Bignamini; Salvatore Cazzato; Renato Cutrera; Giuliana Ferrante; Stefania La Grutta; Amelia Licari; Enrico Lombardi; Fabio Midulla; Giorgio Piacentini; Massimo Pifferi; Francesca Santamaria; Giancarlo Tancredi; Attilio Turchetta
Journal:  Ital J Pediatr       Date:  2020-05-24       Impact factor: 2.638

4.  Discrepancy between Lung Function Measurements at Home and in the Hospital in Children with Asthma and CF.

Authors:  Frederick L G R Gerzon; Quirijn Jöbsis; Michiel A G E Bannier; Bjorn Winkens; Edward Dompeling
Journal:  J Clin Med       Date:  2020-05-26       Impact factor: 4.241

5.  COVID-19 transmission through asymptomatic carriers is a challenge to containment.

Authors:  Xingxia Yu; Rongrong Yang
Journal:  Influenza Other Respir Viruses       Date:  2020-04-15       Impact factor: 4.380

6.  SARS-CoV-2 Infection in Children.

Authors:  Xiaoxia Lu; Liqiong Zhang; Hui Du; Jingjing Zhang; Yuan Y Li; Jingyu Qu; Wenxin Zhang; Youjie Wang; Shuangshuang Bao; Ying Li; Chuansha Wu; Hongxiu Liu; Di Liu; Jianbo Shao; Xuehua Peng; Yonghong Yang; Zhisheng Liu; Yun Xiang; Furong Zhang; Rona M Silva; Kent E Pinkerton; Kunling Shen; Han Xiao; Shunqing Xu; Gary W K Wong
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

7.  Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China.

Authors:  Wenjun Du; Jinhong Yu; Hui Wang; Xiaoguo Zhang; Shouwei Zhang; Qiang Li; Zhongfa Zhang
Journal:  Infection       Date:  2020-04-16       Impact factor: 7.455

Review 8.  COVID-19 epidemic: Disease characteristics in children.

Authors:  Jiatong She; Lanqin Liu; Wenjun Liu
Journal:  J Med Virol       Date:  2020-04-15       Impact factor: 20.693

  8 in total
  5 in total

Review 1.  Re-opening the pediatric pulmonary function laboratory during the ongoing COVID-19 pandemic.

Authors:  Larry C Lands
Journal:  Paediatr Respir Rev       Date:  2022-01-11       Impact factor: 5.526

Review 2.  International consensus on lung function testing during the COVID-19 pandemic and beyond.

Authors:  Aisling McGowan; Pierantonio Laveneziana; Sam Bayat; Nicole Beydon; P W Boros; Felip Burgos; Matjaž Fležar; Monika Franczuk; Maria-Alejandra Galarza; Adrian H Kendrick; Enrico Lombardi; Jellien Makonga-Braaksma; Meredith C McCormack; Laurent Plantier; Sanja Stanojevic; Irene Steenbruggen; Bruce Thompson; Allan L Coates; Jack Wanger; Donald W Cockcroft; Bruce Culver; Karl Sylvester; Frans De Jongh
Journal:  ERJ Open Res       Date:  2022-03-07

Review 3.  Pulmonary function testing during SARS-CoV-2: An ANZSRS/TSANZ position statement.

Authors:  Brigitte M Borg; Christian Osadnik; Keith Adam; David G Chapman; Catherine E Farrow; Vanda Glavas; Kerry Hancock; Celia J Lanteri; Ewan G Morris; Nicholas Romeo; Elena K Schneider-Futschik; Hiran Selvadurai
Journal:  Respirology       Date:  2022-08-10       Impact factor: 6.175

Review 4.  Pediatric Pulmonary Function Testing in COVID-19 Pandemic and Beyond. A Position Statement From the Hellenic Pediatric Respiratory Society.

Authors:  Sotirios Fouzas; Dimos Gidaris; Nikolaos Karantaglis; Harry Opsimos; Emmanouil I Alexopoulos; Konstantinos Douros; Fotios Kirvassilis; Emmanouil Paraskakis; Michael B Anthracopoulos; Markos Marangos; Ioannis Tsanakas
Journal:  Front Pediatr       Date:  2021-05-21       Impact factor: 3.418

Review 5.  Covid-19 and spirometry in this age.

Authors:  Angela Klain; Cristiana Indolfi; Giulio Dinardo; Fabio Decimo; Michele Miraglia Del Giudice
Journal:  Ital J Pediatr       Date:  2022-01-18       Impact factor: 2.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.